Abstract
Docetaxel (taxotere) had successfully prolonged the survival time in a 59-year-old woman with breast cancer having distan metastases to the liver, lung, lymphnodes and bone. Adverse side effects included febrile neutropenia and reactive pleural effusion. The former was avoided by giving fractionated doses, but the later limitted the sequential administration. Despite, a partial response was gained for both the liver and lung metastases, the patient died of brain metastasis.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association)
Paper Title
Journal
Date
